Anticancer Activity of Nicotinamide on Lung Cancer

Clinical trial NCT02416739 · UNKNOWN

Trial details

NCT number: NCT02416739
Sponsor: Il Yeong Park, Ph.D.
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2015-03-01
Primary completion: 2020-03-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.